JPRN-UMIN000004552已完成未知
A comparative trial on adjuvant and clinical effects of influenza vaccine by Kampo formulas in elderly people. - Effect of Kampo formulas on adjuvant effects of influenza vaccine.
niversity of Toyama0 个研究点目标入组 250 人开始时间: 2010年11月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with severe diseases whose serum albumin level is under 2.7 g/dl or concentration of hemoglobin is under 9.0 g/dl. 2. Patients with infections who continue the fever above 38 degrees C 3. Patients who take medicines that have influences on antibody productions for instance steroid preparation and immune -suppressive agents.
研究者
相似试验
尚未招募
不适用
Comparative study of leech therapy with other medicines and therapies in the management of a variety vascular disease.CTRI/2020/07/026265SDM College of Ayurveda Hospital Hassan
尚未招募
Unknown
A Study to Assess the adjuvant effectiveness of kati snan and mula bandha in Vatasthila (Benign Prostatic Hyperplasis)CTRI/2023/08/056293Shri Dhanwantri Ayurvedic College Chandigarh
进行中（未招募）
不适用
Phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma - RTOGEUCTR2005-005177-29-LVEORTC834
进行中（未招募）
1 期
Phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma - RTOGEUCTR2005-005177-29-BEEORTC1,125
进行中（未招募）
不适用
Phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma - RTOGPatients with Glioblastoma MultiformeMedDRA version: 8.1Level: LLTClassification code 10018337Term: Glioblastoma multiformeEUCTR2005-005177-29-DEEORTC1,153